UNSPSC 51422351: Mazipredone hydrochloride

This classification denotes a therapeutic glucocorticoid C26H38N2O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HOX0WI4U1F, chemically known as (11.beta.)-11,17-dihydroxy-21-(4-methyl-1-piperazinyl)pregna-1,4-diene-3,20-dione hydrochloride, but more generally known as mazipredone hydrochloride, which bears US NIH Compound Identifier 6063. European Medicines Agency schedules Mazipredone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14485MIG.

Most nations, for tariff and trade purposes, schedule mazipredone hydrochloride under HS 29372900 and SITC 54153. As of Q4 2014, MAZIPREDONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CN4CCN(CC4)C)O)CCC5=CC(=O)C=C[C@]35C)O.CL.

UNSPSC 51422351 Mazipredone hydrochloride is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though the recent opportunity record shows a mismatch between the code's nominal scope and what is actually being solicited. Seminole County, Florida, the sole recent issuing body in the available data, posted an IFB for Naloxone and Safe Drug Deactivation Systems — neither of which is Mazipredone hydrochloride. The code appears to see limited recent state and local procurement activity aligned with its product name, and the single tagged opportunity is for naloxone, an opioid antagonist used in overdose response, which falls outside the code's stated pharmaceutical category.

Seminole County, Florida, released IFB 60459723LAS on June 30, 2026, requesting 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with responses due July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, with pricing submitted on a fixed-fee basis including all shipping and delivery costs. Vendors must satisfy drug-free workplace certification, E-Verify compliance, and standard insurance requirements; the procurement potentially draws federal funding through FEMA and subjects contractors to adherence with the Clean Air Act and Federal Water Pollution Control Act. The code shows no clear concentration across multiple jurisdictions or states at this time, and business development professionals should verify whether the Mazipredone hydrochloride code accurately reflects the pharmaceutical products their firm supplies before pursuing opportunities tagged to it.